Patient Engagement With Digital Health Tools in Rheumatology

July 15, 2022 updated by: Nikita Arumalla, Guy's and St Thomas' NHS Foundation Trust
The purpose of this study is to evaluate the patient engagement with digital tools for diagnosis and monitoring of disease in rheumatology services

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The investigators plan to undertake a mixed methods study to investigate a digital algorithm to potentially inform triage of new patient referral to rheumatology services, as well as to inform follow up review schedules. Current practice at out hospital is to ask all newly referred patients to complete a pre-appointment digital questionnaire prior to their clinic visit. Patients who need follow up are then routinely invited to continue to return interval questionnaires related to their symptoms between clinic visits.

The investigators believe that the questionnaire responses could enable appropriate (and safe) allocation to a particular clinic (e.g. urgent early arthritis clinic or general rheumatology clinic for a new referral), or define an appropriate clinic follow up interval for a repeat visit for patients with a rheumatic disease.

Our study aims to evaluate these questionnaires using data collected from routine clinical practice, as well a series of semi-structured interviews with service users.

Study Type

Observational

Enrollment (Anticipated)

3000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All new patients referred to rheumatology outpatients + patients with inflammatory arthritis under follow up in rheumatology outpatients

Description

Inclusion Criteria: quantitative phase:

  • Aged 18 years and above
  • Able to complete the questionnaire in English

    1. New patient pre-appointment questionnaires

  • Referred as a new patient to the rheumatology outpatient department at Guys and St Thomas' Trust between 01/01/2019 to 01/10/2023 and sent a digital pre-appointment questionnaire
  • Electronic patient notes recorded between 01/01/2019 to 01/10/2024

    2. Follow up patients PROM questionnaires

  • Patients under followup of the rheumatology department at Guys and St Thomas' Trust with a diagnosis of rheumatoid arthritis, psoriatic arthritis or axial spondyloarthropathy who have been added to the remote monitoring program between 01/01/2019 to 01/10/2023
  • Electronic patient notes recorded between 01/01/2019 to 01/10/2024

Inclusion criteria: qualitative phase:

  • Aged 18 years and above

    1. New patient pre-appointment questionnaires

  • Referred as a new patient to the rheumatology outpatient department at Guys and St Thomas' Trust between 01/01/2019 to 01/10/2023 and sent a digital pre-appointment questionnaire
  • Able to communicate in English or any language offered for audio interpreting by the LanguageLine service

    2. Follow up patients PROM questionnaires

  • Patients under followup of the rheumatology department at Guys and St Thomas' Trust with a diagnosis of rheumatoid arthritis, psoriatic arthritis or axial spondyloarthropathy who have been added to the remote monitoring program between 01/01/2019 to 01/10/2023
  • Able to communicate in English or any language offered for audio interpreting by the LanguageLine service

Exclusion Criteria: quantitative phase:

  • Under 18 years of age
  • Unable to complete study questionnaires

Exclusion criteria: qualitative phase:

  • Under 18 years of age
  • Patients lacking the capacity to consent for themselves for the semi-structured interview

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
New patients
All new referrals seen in the rheumatology outpatients department, completing pre-appointment digital questionnaires
Questionnaires completed as part of routine care - this is an observational study
Semi-structured interview to review factors involved in patients engaging or not-engaging with the digital tools
Follow-up patients
Patient with inflammatory arthritis completing ePROMs [electronic Patient Reported Outcome Measures] through the remote monitoring platform
Questionnaires completed as part of routine care - this is an observational study
Semi-structured interview to review factors involved in patients engaging or not-engaging with the digital tools

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with a non-inflammatory diagnosis
Time Frame: 3 years
Clinician assessed diagnosis as categorised into inflammatory [e.g. rheumatoid arthritis] or non-inflammatory [e.g osteoarthritis or fibromyalgia]
3 years
Clinician assessed DAS-28 score for patients with rheumatoid arthritis
Time Frame: 3 years
Clinician assessment of disease activity at next follow-up visit for remote monitoring questionnaires
3 years
Clinician assessed PsARC score for patients with psoriatic arthritis
Time Frame: 3 years
Clinician assessment of disease activity at next follow-up visit for remote monitoring questionnaires
3 years
Rate of response to digital questionnaires
Time Frame: 3 years
Proportion of patients completing the new patient pre-appointment and follow-up remote monitoring questionnaires.
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PHQ8 scores in new patients completing pre-appointment questionnaires
Time Frame: 3 years
To estimate the prevalence of depression in new referrals to the rheumatology service. Score range 0 to 24, with higher score indicating more severe depression
3 years
GAD7 scores in new patients completing pre-appointment questionnaires
Time Frame: 3 years
To estimate the prevalence of anxiety in new referrals to the rheumatology service. Score range 0 to 21, with higher score indicating more severe anxiety
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Toby Garrood, FRCP, PhD, Guy's and St Thomas' NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

July 1, 2022

Primary Completion (ANTICIPATED)

October 1, 2024

Study Completion (ANTICIPATED)

July 1, 2025

Study Registration Dates

First Submitted

June 22, 2022

First Submitted That Met QC Criteria

July 15, 2022

First Posted (ACTUAL)

July 19, 2022

Study Record Updates

Last Update Posted (ACTUAL)

July 19, 2022

Last Update Submitted That Met QC Criteria

July 15, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EDGE 147423

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatic Disease

Clinical Trials on Questionnaire

Subscribe